Ando, Apigyn P.

HRN: 07-94-01  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/28/2022
CEFUROXIME 1.5GM (VIAL)
04/28/2022
04/28/2022
IVT
1.5g
On Call To OR
For LTCS, Surgical Prophylaxis
Waiting Final Action 
04/28/2022
CEFUROXIME 750MG (VIAL)
04/28/2022
04/29/2022
IV
3 Doses
Q8
S/P Repeat CS With Bilateral Tubal Ligation
Waiting Final Action 
04/29/2022
MUPIROCIN 2%, 15G (TUBE)
04/29/2022
05/06/2022
PER DERMAL
0.1g
BID
Post-op Wound Prophylaxis
Waiting Final Action 
04/29/2022
CEFUROXIME 500MG (TAB)
04/29/2022
05/06/2022
PO
500mg
BID
Shift To Oral; Post-op Prophylaxis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: